Modeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting

The therapeutic interventions of human hypertrophic scars (HHS) remain puzzle largely due to the lack of accepted models. Current HHS models are limited by their inability to mimic native scar architecture and associated pathological microenvironments. Here, we create a 3D functional HHS model by pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yao Bin, Zhu Dongzhen, Cui Xiaoli, Enhe jirigala, Song Wei, Li Zhao, Hu Tian, Zhu Ping, Li Jianjun, Wang Yuzhen, Zhang Yijie, Fu Xiaobing, Huang Sha
Formato: article
Lenguaje:EN
Publicado: KeAi Communications Co., Ltd. 2022
Materias:
Acceso en línea:https://doaj.org/article/3189b26a3550452fbda9c0acabe746b4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3189b26a3550452fbda9c0acabe746b4
record_format dspace
spelling oai:doaj.org-article:3189b26a3550452fbda9c0acabe746b42021-11-28T04:35:28ZModeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting2452-199X10.1016/j.bioactmat.2021.09.004https://doaj.org/article/3189b26a3550452fbda9c0acabe746b42022-04-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2452199X2100414Xhttps://doaj.org/toc/2452-199XThe therapeutic interventions of human hypertrophic scars (HHS) remain puzzle largely due to the lack of accepted models. Current HHS models are limited by their inability to mimic native scar architecture and associated pathological microenvironments. Here, we create a 3D functional HHS model by preformed cellular aggregates (PCA) bioprinting, firstly developing bioink from scar decellularized extracellular matrix (ECM) and alginate-gelatin (Alg-Gel) hydrogel with suitable physical properties to mimic the microenvironmental factors, then pre-culturing patient-derived fibroblasts in this bioink to preform the topographic cellular aggregates for sequent printing. We confirm the cell aggregates preformed in bioink displayed well defined aligned structure and formed functional scar tissue self-organization after bioprinting, hence showing the potential of creating HHS models. Notably, these HHS models exhibit characteristics of early-stage HHS in gene and protein expression, which significantly activated signaling pathway related to inflammation and cell proliferation, and recapitulate in vivo tissue dynamics of scar forming. We also use the in vitro and in vivo models to define the clinically observed effects to treatment with concurrent anti-scarring drugs, and the data show that it can be used to evaluate the potential therapeutic target for drug testing. The ideal humanized scar models we present should prove useful for studying critical mechanisms underlying HHS and to rapidly test new drug targets and develop patient-specific optimal therapeutic strategies in the future.Yao BinZhu DongzhenCui XiaoliEnhe jirigalaSong WeiLi ZhaoHu TianZhu PingLi JianjunWang YuzhenZhang YijieFu XiaobingHuang ShaKeAi Communications Co., Ltd.articleHypertrophic scar modelPreformed cell aggregates3D bioprintingMicroenvironmental cuesDrug screeningMaterials of engineering and construction. Mechanics of materialsTA401-492Biology (General)QH301-705.5ENBioactive Materials, Vol 10, Iss , Pp 247-254 (2022)
institution DOAJ
collection DOAJ
language EN
topic Hypertrophic scar model
Preformed cell aggregates
3D bioprinting
Microenvironmental cues
Drug screening
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
spellingShingle Hypertrophic scar model
Preformed cell aggregates
3D bioprinting
Microenvironmental cues
Drug screening
Materials of engineering and construction. Mechanics of materials
TA401-492
Biology (General)
QH301-705.5
Yao Bin
Zhu Dongzhen
Cui Xiaoli
Enhe jirigala
Song Wei
Li Zhao
Hu Tian
Zhu Ping
Li Jianjun
Wang Yuzhen
Zhang Yijie
Fu Xiaobing
Huang Sha
Modeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting
description The therapeutic interventions of human hypertrophic scars (HHS) remain puzzle largely due to the lack of accepted models. Current HHS models are limited by their inability to mimic native scar architecture and associated pathological microenvironments. Here, we create a 3D functional HHS model by preformed cellular aggregates (PCA) bioprinting, firstly developing bioink from scar decellularized extracellular matrix (ECM) and alginate-gelatin (Alg-Gel) hydrogel with suitable physical properties to mimic the microenvironmental factors, then pre-culturing patient-derived fibroblasts in this bioink to preform the topographic cellular aggregates for sequent printing. We confirm the cell aggregates preformed in bioink displayed well defined aligned structure and formed functional scar tissue self-organization after bioprinting, hence showing the potential of creating HHS models. Notably, these HHS models exhibit characteristics of early-stage HHS in gene and protein expression, which significantly activated signaling pathway related to inflammation and cell proliferation, and recapitulate in vivo tissue dynamics of scar forming. We also use the in vitro and in vivo models to define the clinically observed effects to treatment with concurrent anti-scarring drugs, and the data show that it can be used to evaluate the potential therapeutic target for drug testing. The ideal humanized scar models we present should prove useful for studying critical mechanisms underlying HHS and to rapidly test new drug targets and develop patient-specific optimal therapeutic strategies in the future.
format article
author Yao Bin
Zhu Dongzhen
Cui Xiaoli
Enhe jirigala
Song Wei
Li Zhao
Hu Tian
Zhu Ping
Li Jianjun
Wang Yuzhen
Zhang Yijie
Fu Xiaobing
Huang Sha
author_facet Yao Bin
Zhu Dongzhen
Cui Xiaoli
Enhe jirigala
Song Wei
Li Zhao
Hu Tian
Zhu Ping
Li Jianjun
Wang Yuzhen
Zhang Yijie
Fu Xiaobing
Huang Sha
author_sort Yao Bin
title Modeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting
title_short Modeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting
title_full Modeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting
title_fullStr Modeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting
title_full_unstemmed Modeling human hypertrophic scars with 3D preformed cellular aggregates bioprinting
title_sort modeling human hypertrophic scars with 3d preformed cellular aggregates bioprinting
publisher KeAi Communications Co., Ltd.
publishDate 2022
url https://doaj.org/article/3189b26a3550452fbda9c0acabe746b4
work_keys_str_mv AT yaobin modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT zhudongzhen modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT cuixiaoli modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT enhejirigala modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT songwei modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT lizhao modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT hutian modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT zhuping modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT lijianjun modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT wangyuzhen modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT zhangyijie modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT fuxiaobing modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
AT huangsha modelinghumanhypertrophicscarswith3dpreformedcellularaggregatesbioprinting
_version_ 1718408308627341312